Navigation Links
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results
Date:2/11/2009

(A Development Stage Enterprise) CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Three Months Ended Year Ended Dec. 31, Dec. 31, Dec. 31, Dec. 31, 2008 2007 2008 2007 Revenues from services $- $- $- $- Operating expenses: Research and development 3,559,543 12,574,735 23,935,541 47,234,867 General and administrative 4,095,118 9,472,938 28,909,580 32,803,508 Total operating expenses 7,654,661 22,047,673 52,845,121 80,038,375 Loss from operations (7,654,661) (22,047,673) (52,845,121) (80,038,375) Interest income 150,642 1,299,076 1,780,880 5,907,219 Other income - - - 71,345 Total other income, net 150,642 1,299,076 1,780,880 5,978,564 Loss before tax provision (7,504,019) (20,748,597) (51,064,241) (74,059,811) Tax provision - (191) - 9,879 Net loss $(7,504,019) $(20,748,406) $(51,064,241) $(74,069,690) Basic and diluted net loss per share attributable to common stockholders $(0.28) $(0.78) $(1.92) $(2.81) Shares used in calculation of basic and diluted net loss per share attributable to common stockholders 26,652,187 26,644,540 26,650,126 26,360,177 VANDA PHARMACEUTICALS INC. (A Development Stage Enterprise) CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) December 31, December 31,
'/>"/>
SOURCE Vanda Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Vanda Pharmaceuticals Reports Third Quarter 2008 Results
2. Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights
3. Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008
4. LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
5. Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
6. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference
8. Sagent Pharmaceuticals Announces Expansion of Cefazolin Product Line to Include Cefazolin for Injection, USP in 500mg Single-Dose Vial
9. PacificGMP and LigoCyte Pharmaceuticals Announce cGMP Manufacturing Collaboration
10. Diffusion Pharmaceuticals Announces Completion of a $2.9 Million Private Placement and Company Presentations at Upcoming Industry Conferences in Geneva, Switzerland and Naples, Florida
11. Tigris Pharmaceuticals Files IND Application for GGTI-2418
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... August 22, 2014 Ophthalmic drug ... interesting and challenging endeavors as the anatomy, physiology ... properties to the foreign substances. Ocular drug delivery ... self medication and minimal use of needles; also ... drugs and provides specific targeting within the ocular ...
(Date:8/22/2014)... The AMA is pleased to share with ... that Alaska Governor Sean Parnell has signed House Bill ... use of Unmanned Aircraft Systems and the continuation of ... that it is, “An Act relating to unmanned aircraft ... aircraft system.” It defines State of Alaska laws regarding ...
(Date:8/21/2014)... , Aug. 21, 2014  BioSpecifics Technologies ... company developing first in class collagenase-based products marketed ... CCH) in the U.S. and XIAPEX ® ... results from a randomized, double-blind Phase 2a study ... or edematous fibrosclerotic panniculopathy. The results showed that ...
(Date:8/21/2014)... Dallas, Texas (PRWEB) August 21, 2014 ... Global Seaweed Fertilizer Industry” is a professional ... Fertilizer market. The report provides basic Seaweed ... application, and industry chain structure as well ... international market analysis, including domestic market as ...
Breaking Biology Technology:Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 4State of Alaska Signs Unmanned Aircraft Systems Bill 2BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 2BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 3BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 4BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 5Internationals Seaweed Fertilizer Industry 2014 Development Trend Analysis in New Research Study at DeepResearchReports.com 2Internationals Seaweed Fertilizer Industry 2014 Development Trend Analysis in New Research Study at DeepResearchReports.com 3
... already lives in areas struggling to keep up with the ... double. Some countries have met the challenge by tapping into ... such as the much-depleted Jordan River have demonstrated, many ... Yale University study argues that seawater desalination should play an ...
... Genetics, Inc. (OTCQB: ILIU) announced today that it will ... at 9:30 a.m. EDT to discuss the Company,s second quarter ... (domestic) or 631-291-4550 (international). The live Webcast and replay access ... of Interleukin Genetics, Inc.,s Website at http://www.ilgenetics.com . ...
... SynCo Bio Partners B.V., one of the ... aseptic filling facility is again fully operational and SynCo has ... clients after the expansion of its Class A zone.   ... an important milestone in SynCo,s strategy in supporting its clients ...
Cached Biology Technology:Better desalination technology key to solving world's water shortage 2Interleukin Genetics, Inc. Announces Conference Call to Discuss Second Quarter 2011 Results 2SynCo Bio Partners Expands the Class A Zone in its Aseptic Filling Facility 2
(Date:8/21/2014)... intake, health and quality of life of older adults ... the University of Waterloo receiving close to $1.5 million ... (CIHR). , Professor Heather Keller, of the Faculty ... research chair in nutrition and aging, will receive $979,000 ... in long-term care homes are poorly nourished. The project ...
(Date:8/21/2014)... to Wednesday, Oct. 18-22, 2014 , WHERE: ... Drive, San Diego, CA 92101 , WHAT: ... presentations of the latest research in human genetics. ... featuring high-scoring abstracts on rare genetic variants in ... and treatment for sun sensitivity (Saturday, Oct. 18, ...
(Date:8/21/2014)... University have developed a novel and versatile modeling strategy ... creating new materials as well as for studying polyelectrolytes, ... us to model much larger and more complex polyelectrolyte ... Nan Li, lead author of a paper on the ... of Materials Science and Engineering. "This is a big ...
Breaking Biology News(10 mins):Grants will fund landmark aging research at Waterloo 2American Society of Human Genetics 2014 Annual Meeting 2Researchers develop models to study polyelectrolytes, including DNA and RNA 2
... products used in consumer goods end up unchanged in ... the environment and human health, researchers from the Autonomous ... to effectively predict what will happen to current and ... are increasingly diverse and increasingly used, are "partially" metabolised ...
... University of Minnesota discovery may help bone cancer patients ... published in the September issue of Bone . ... aggressiveness of the disease can vary from patient to ... patients respond remarkably well to conventional therapies. Their disease ...
... 27, 2011) SomaLogic, Inc. and New England Biolabs, ... an exclusive licensing agreement whereby SomaLogic will provide specific ... and future NEB nucleic acid amplification and polymerase chain ... binding reagents based on chemically modified "aptamers," or short ...
Cached Biology News:New model predicts environmental effect of pharmaceutical products 2U researchers look to dogs to better understand intricacies of bone cancer 2
... fully automated solution for cell culture ... for cell-line maintenance, expansion, harvesting and ... built upon standard, industry proven components: ... configuration capable of both rapid bulk ...
... provide custom microplate coating using advanced automated high throughput microplate ... formats. We can also accommodate virtually any lot size of ... , 8 and 12 ... 384 well microplate, ...
... The Bio-Plex maintenance, calibration, and ... custom 96-well plate used for ... calibration procedures using the Bio-Plex ... plate is for use with ...
... Agencourt offers single pass sequencing ... service is fueled by our high ... 20 million Phred20 bases per day. ... single pass sequencing customers are rapid ...
Biology Products: